Synthesis and pKa values of 2-(3- and 4- pentafluorosulfanylphenyl)-2-fluorocyclopropylamines

Journal of Fluorine Chemistry

Volumn 155, Issue , 2013, Pages 102-109

  Schinor, Benjamin ^a   Wibbeling, Birgit ^a   Haufe, Günter ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Fluorostyrenes; 2 Fluorocyclopropanecarboxylic acids; 2 Fluorocyclopropylamines; Pentafluorosulfanyl (SF5) substituent; pKa values; Stereochemistry

Indexed keywords

EID: 84884501109     PISSN: 00221139     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfluchem.2013.07.003     Document Type: Article

References (31)

1. 6 V.A. Soloshonok, Fluorine-Containing Synthons, ACS Symposium Series vol. 911 2005 American Chemical Society Washington 87 118
2. P. Kirsch, and G.V. Röschenthaler Functional Compounds Based on Hypervalent Sulfur Fluorides V.A. Soloshonok, K. Mikami, T. Yamazaki, J.T. Welch, J.F. Honek, Current Fluoroorganic Chemistry, New Synthetic Directions, Technologies, Materials, and Biological Applications, ACS Symposium Series vol. 949 2006 American Chemical Society Washington 221 243
3. P. Kirsch Modern Fluoroorganic Chemistry: Synthesis, Reactivity Applications 2nd ed. 2013 Wiley-VCH Weinheim 318
4. S. Altomonte, and M. Zanda J. Fluorine Chem. 143 2012 57 93
5. J.E. True, T.D. Thomas, R.W. Winter, and G.L. Gard Inorg. Chem. 42 2003 4437 4441
6. L.J. Saethre, N. Berrah, J.D. Bozek, K.J. Borve, T.X. Carroll, E. Kukk, G.L. Gard, R. Winter, and T.D. Thomas Pentafluorosulfanyl Serotonin Analogs: Synthesis, Charakterization and Biological Activity J. Am. Chem. Soc. 123 2001 10729 10737
7. J.T. Welch, and D. Lim Pentafluorosulfanyl Serotonin Analogs: Synthesis, Charakterization and Biological Activity A.A. Gakh, K.L. Kirk, Fluorinated Heterocycles, ACS Symposium Series vol. 1003 2009 American Chemical Society Washington 165 181
8. J.T. Welch Applications of Pentafluorosulfanyl Substitution in Life Sciences Research V. Gouverneur, K. Müller, Fluorine in Pharmaceutical and Medicinal Chemistry. From Biophysical Aspects to Clinical Applications 2012 Imperial College Press London 175 207
9. M. Schlosser Angew. Chem. Int. Ed. 37 1998 1497 1513
10. H.J. Böhm, D. Banner, S. Bendels, M. Kansy, B. Kuhn, K. Müller, U. Obst-Sander, and M. Stahl Chembiochem 5 2004 637 643
11. D. O'Hagan Chem. Soc. Rev. 37 2008 308 319
12. W.K. Hagmann J. Med. Chem. 51 2008 4359 4369
13. T. Yamazaki, T. Taguchi, and I. Ojima Unique Properties of Fluorine and Their Relevance to Medicinal Chemistry and Chemical Biology I. Ojima, Fluorine in Medicinal Chemistry and Chemical Biology 2009 Wiley-Blackwell Chichester 3 46
14. I. Hyla-Kryspin, S. Grimme, S. Hruschka, and G. Haufe Org. Biomol. Chem. 6 2008 4167 4175
15. S. Yoshida, O.G.J. Meyer, T.C. Rosen, G. Haufe, S. Ye, M.J. Sloan, and K.L. Kirk J. Med. Chem. 47 2004 1796 1806
16. S. Hruschka, T.C. Rosen, S. Yoshida, K.L. Kirk, R. Fröhlich, B. Wibbeling, and G. Haufe Bioorg. Med. Chem. 16 2008 7148 7166
17. O.G.J. Meyer, R. Fröhlich, and G. Haufe Synthesis 2000 1479 1490
18. T.C. Rosen, S. Yoshida, R. Fröhlich, K.L. Kirk, and G. Haufe J. Med. Chem. 47 2004 5860 5871
19. W.A. Sheppard J. Am. Chem. Soc. 84 1962 3072 3076
20. W.A. Sheppard J. Am. Chem. Soc. 84 1962 3064 3072
21. S.P. Gibson, C. Lauret, US-Pat. 2008/194694 A1 (Pfizer).
22. S.N. Comlay, J.C. Hannam, W. Howson, C. Lauret, Y.A. Sabnis, US-Pat. 2008/200540 A1 (Pfizer).
23. Z. Otwinowski, and W. Minor Methods Enzymol. 276 1997 307 326
24. Z. Otwinowski, D. Borek, W. Majewski, and W. Minor Acta Crystallogr. A59 2003 228 234
25. G.M. Sheldrick Acta Crystallogr. A46 1990 467 473
26. G.M. Sheldrick Acta Crystallogr. A64 2008 112 122
27. G. Alvernhe, A. Laurent, and G. Haufe Synthesis 1987 562 564
28. G. Haufe, G. Alvernhe, A. Laurent, T. Ernet, O. Goj, S. Kröger, and A. Sattler Org. Synth. 76 1999 159 168
29. L. Eckes, and M. Hanack Synthesis 1978 217 219
30. H. Saga, T. Hamatani, Y. Gugginberg, and M. Schlosser Tetrahedron 46 1990 4255 4260
31. T. Ernet, and G. Haufe Tetrahedron Lett. 37 1996 7251 7252